Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design Approach

PJC. van Lonkhuizen, NJH. Vegt, E. Meijer, E. van Duijn, ST. de Bot, J. Klempíř, W. Frank, GB. Landwehrmeyer, A. Mühlbäck, J. Hoblyn, F. Squitieri, P. Foley, NH. Chavannes, AW. Heemskerk

. 2021 ; 12 (-) : 719460. [pub] 20210913

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22001737

Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disease that affects the quality of life (QoL) of HD gene expansion carriers (HDGECs) and their partners. Although HD expertise centers have been emerging across Europe, there are still some important barriers to care provision for those affected by this rare disease, including transportation costs, geographic distance of centers, and availability/accessibility of these services in general. eHealth seems promising in overcoming these barriers, yet research on eHealth in HD is limited and fails to use telehealth services specifically designed to fit the perspectives and expectations of HDGECs and their families. In the European HD-eHelp study, we aim to capture the needs and wishes of HDGECs, partners of HDGECs, and health care providers (HCPs) in order to develop a multinational eHealth platform targeting QoL of both HDGECs and partners at home. Methods: We will employ a participatory user-centered design (UCD) approach, which focusses on an in-depth understanding of the end-users' needs and their contexts. Premanifest and manifest adult HDGECs (n = 76), partners of HDGECs (n = 76), and HCPs (n = 76) will be involved as end-users in all three phases of the research and design process: (1) Exploration and mapping of the end-users' needs, experiences and wishes; (2) Development of concepts in collaboration with end-users to ensure desirability; (3) Detailing of final prototype with quick review rounds by end-users to create a positive user-experience. This study will be conducted in the Netherlands, Germany, Czech Republic, Italy, and Ireland to develop and test a multilingual platform that is suitable in different healthcare systems and cultural contexts. Discussion: Following the principles of UCD, an innovative European eHealth platform will be developed that addresses the needs and wishes of HDGECs, partners and HCPs. This allows for high-quality, tailored care to be moved partially into the participants' home, thereby circumventing some barriers in current HD care provision. By actively involving end-users in all design decisions, the platform will be tailored to the end-users' unique requirements, which can be considered pivotal in eHealth services for a disease as complex and rare as HD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001737
003      
CZ-PrNML
005      
20220112153709.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fneur.2021.719460 $2 doi
035    __
$a (PubMed)34589047
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a van Lonkhuizen, Pearl J C $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands $u National eHealth Living Lab, Leiden University Medical Center, Leiden, Netherlands $u Huntington Center Topaz Overduin, Katwijk, Netherlands
245    10
$a Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design Approach / $c PJC. van Lonkhuizen, NJH. Vegt, E. Meijer, E. van Duijn, ST. de Bot, J. Klempíř, W. Frank, GB. Landwehrmeyer, A. Mühlbäck, J. Hoblyn, F. Squitieri, P. Foley, NH. Chavannes, AW. Heemskerk
520    9_
$a Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disease that affects the quality of life (QoL) of HD gene expansion carriers (HDGECs) and their partners. Although HD expertise centers have been emerging across Europe, there are still some important barriers to care provision for those affected by this rare disease, including transportation costs, geographic distance of centers, and availability/accessibility of these services in general. eHealth seems promising in overcoming these barriers, yet research on eHealth in HD is limited and fails to use telehealth services specifically designed to fit the perspectives and expectations of HDGECs and their families. In the European HD-eHelp study, we aim to capture the needs and wishes of HDGECs, partners of HDGECs, and health care providers (HCPs) in order to develop a multinational eHealth platform targeting QoL of both HDGECs and partners at home. Methods: We will employ a participatory user-centered design (UCD) approach, which focusses on an in-depth understanding of the end-users' needs and their contexts. Premanifest and manifest adult HDGECs (n = 76), partners of HDGECs (n = 76), and HCPs (n = 76) will be involved as end-users in all three phases of the research and design process: (1) Exploration and mapping of the end-users' needs, experiences and wishes; (2) Development of concepts in collaboration with end-users to ensure desirability; (3) Detailing of final prototype with quick review rounds by end-users to create a positive user-experience. This study will be conducted in the Netherlands, Germany, Czech Republic, Italy, and Ireland to develop and test a multilingual platform that is suitable in different healthcare systems and cultural contexts. Discussion: Following the principles of UCD, an innovative European eHealth platform will be developed that addresses the needs and wishes of HDGECs, partners and HCPs. This allows for high-quality, tailored care to be moved partially into the participants' home, thereby circumventing some barriers in current HD care provision. By actively involving end-users in all design decisions, the platform will be tailored to the end-users' unique requirements, which can be considered pivotal in eHealth services for a disease as complex and rare as HD.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vegt, Niko J H $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands $u National eHealth Living Lab, Leiden University Medical Center, Leiden, Netherlands
700    1_
$a Meijer, Eline $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands $u National eHealth Living Lab, Leiden University Medical Center, Leiden, Netherlands
700    1_
$a van Duijn, Erik $u Huntington Center Topaz Overduin, Katwijk, Netherlands $u Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands
700    1_
$a de Bot, Susanne T $u Department of Neurology, Leiden University Medical Center, Leiden, Netherlands
700    1_
$a Klempíř, Jiří $u Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Frank, Wiebke $u Department of Neurology, University Hospital Ulm, Ulm, Germany
700    1_
$a Landwehrmeyer, G Bernhard $u Department of Neurology, University Hospital Ulm, Ulm, Germany
700    1_
$a Mühlbäck, Alzbeta $u Department of Neurology, University Hospital Ulm, Ulm, Germany
700    1_
$a Hoblyn, Jennifer $u Bloomfield Hospital, Trinity College Dublin, Dublin, Ireland
700    1_
$a Squitieri, Ferdinando $u Huntington and Rare Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy
700    1_
$a Foley, Peter $u Department of Clinical Neurosciences, Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom
700    1_
$a Chavannes, Niels H $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands $u National eHealth Living Lab, Leiden University Medical Center, Leiden, Netherlands
700    1_
$a Heemskerk, Anne-Wil $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands $u Huntington Center Topaz Overduin, Katwijk, Netherlands
773    0_
$w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 12, č. - (2021), s. 719460
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34589047 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153705 $b ABA008
999    __
$a ind $b bmc $g 1745595 $s 1152884
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 719460 $e 20210913 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
LZP    __
$a Pubmed-20220107

Find record

Citation metrics

Archiving options